Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $2.2 million.

  • Abeona Therapeutics' Prepaid Assets rose 11980.1% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 11980.1%. This contributed to the annual value of $1.1 million for FY2024, which is 5679.01% up from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Prepaid Assets is $2.2 million, which was up 11980.1% from $2.1 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Prepaid Assets high stood at $2.4 million for Q4 2021, and its period low was $424000.0 during Q4 2022.
  • Over the past 5 years, Abeona Therapeutics' median Prepaid Assets value was $1.3 million (recorded in 2021), while the average stood at $1.4 million.
  • Per our database at Business Quant, Abeona Therapeutics' Prepaid Assets plummeted by 8216.24% in 2022 and then skyrocketed by 11980.1% in 2025.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Prepaid Assets stood at $2.4 million in 2021, then plummeted by 82.16% to $424000.0 in 2022, then surged by 71.93% to $729000.0 in 2023, then surged by 56.79% to $1.1 million in 2024, then soared by 93.26% to $2.2 million in 2025.
  • Its Prepaid Assets was $2.2 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.0 million in Q1 2025.